Jan Steffel

21.3k total citations · 1 hit paper
171 papers, 4.5k citations indexed

About

Jan Steffel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Jan Steffel has authored 171 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 18 papers in Internal Medicine. Recurrent topics in Jan Steffel's work include Cardiac Arrhythmias and Treatments (87 papers), Cardiac pacing and defibrillation studies (68 papers) and Atrial Fibrillation Management and Outcomes (59 papers). Jan Steffel is often cited by papers focused on Cardiac Arrhythmias and Treatments (87 papers), Cardiac pacing and defibrillation studies (68 papers) and Atrial Fibrillation Management and Outcomes (59 papers). Jan Steffel collaborates with scholars based in Switzerland, Germany and United States. Jan Steffel's co-authors include Thomas F. Lüscher, Felix C. Tanner, Franz R. Eberli, Michael Joner, Gaku Nakazawa, Renu Virmani, Frank Ruschitzka, Alexander Akhmedov, Fırat Duru and David Hürlimann and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jan Steffel

150 papers receiving 4.4k citations

Hit Papers

Drug-Eluting Stent and Coronary Thrombosis 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug-Eluting Stent and Coronary Thrombosis
    2007 672 citations Thomas F. Lüscher, Jan Steffel et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Steffel Switzerland 36 3.1k 1.2k 554 397 356 171 4.5k
Jean‐François Tanguay Canada 35 2.9k 1.0× 1.8k 1.5× 664 1.2× 495 1.2× 490 1.4× 166 4.5k
Jonathan D. Marmur United States 35 2.0k 0.7× 1.8k 1.5× 644 1.2× 438 1.1× 614 1.7× 148 4.4k
Juan F. Viles-González United States 31 2.6k 0.8× 684 0.6× 186 0.3× 292 0.7× 538 1.5× 82 3.6k
Nauder Faraday United States 27 1.5k 0.5× 653 0.5× 356 0.6× 380 1.0× 326 0.9× 79 2.8k
Seiji Hokimoto Japan 30 1.8k 0.6× 988 0.8× 321 0.6× 181 0.5× 431 1.2× 166 3.1k
Axel Schlitt Germany 31 1.5k 0.5× 1.0k 0.8× 558 1.0× 324 0.8× 267 0.8× 143 3.5k
T. Brett Reece United States 35 2.0k 0.7× 2.1k 1.7× 517 0.9× 198 0.5× 1.6k 4.4× 181 5.2k
Michael T. Watkins United States 33 1.6k 0.5× 1.5k 1.2× 550 1.0× 259 0.7× 1.5k 4.3× 143 4.4k
Nicolas Amabile France 33 2.0k 0.7× 1.4k 1.2× 1.8k 3.3× 187 0.5× 975 2.7× 135 4.8k
Stephan H. Schirmer Germany 28 1.4k 0.5× 543 0.4× 523 0.9× 165 0.4× 190 0.5× 82 2.4k

Countries citing papers authored by Jan Steffel

Since Specialization
Citations

This map shows the geographic impact of Jan Steffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Steffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Steffel more than expected).

Fields of papers citing papers by Jan Steffel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Steffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Steffel. The network helps show where Jan Steffel may publish in the future.

Co-authorship network of co-authors of Jan Steffel

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Steffel. A scholar is included among the top collaborators of Jan Steffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Steffel. Jan Steffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trenson, Sander, Peter C. Kahr, Bert Vandenberk, et al.. (2025). Long-Term Nonprogression Is a Form of Response to Cardiac Resynchronization Therapy. JACC Advances. 4(8). 101909–101909.
2.
Kirchhof, Paulus, Ameet Bakhai, Carlo de Asmundis, et al.. (2024). Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study. International Journal of Cardiology. 408. 132118–132118. 1 indexed citations
3.
Zimerman, André, Eugene Braunwald, Jan Steffel, et al.. (2024). Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation. JAMA Cardiology. 9(9). 817–817. 11 indexed citations
4.
Trenson, Sander, Gábor Vörös, Pieter Martens, et al.. (2024). Landmark Evolutions in Time and Indication for Cardiac Resynchronization Therapy: Results from a Multicenter Retrospective Registry. Journal of Clinical Medicine. 13(7). 1903–1903. 2 indexed citations
5.
6.
7.
Steffel, Jan, Daniel Höfer, Ardan M. Saguner, et al.. (2023). 3D Atrial Strain for Predicting Recurrence of Atrial Fibrillation after Pulmonary Vein Isolation. Journal of Clinical Medicine. 12(11). 3696–3696. 5 indexed citations
8.
Dougoud, Svetlana, Markus Arnold, Christos T. Nakas, et al.. (2023). The Role of Electrocardiographic Markers for Predicting Atrial Fibrillation in Patients with Acute Ischemic Stroke: Data from the BIOSIGNAL Cohort Study. Journal of Clinical Medicine. 12(21). 6830–6830. 2 indexed citations
9.
Trenson, Sander, Gábor Vörös, Pieter Martens, et al.. (2023). Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis. European Journal of Heart Failure. 26(2). 511–520. 4 indexed citations
10.
Kirchhof, Paulus, Ladislav Pecen, Ameet Bakhai, et al.. (2022). Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care. European Heart Journal - Cardiovascular Pharmacotherapy. 9(1). 47–57. 9 indexed citations
11.
Akhtar, Zaki, Manav Sohal, Christoph Starck, et al.. (2021). Persistent left superior vena cava transvenous lead extraction: A European experience. Journal of Cardiovascular Electrophysiology. 33(1). 102–108. 4 indexed citations
12.
Steffel, Jan, John W. Eikelboom, Sonia S. Anand, et al.. (2020). The COMPASS Trial. Circulation. 142(1). 40–48. 83 indexed citations
13.
Camm, A. John, Gabriele Accetta, Wael Al Mahmeed, et al.. (2017). Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry. BMJ Open. 7(3). e014579–e014579. 31 indexed citations
14.
Breitenstein, Alexander, Ardan M. Saguner, Markus J. Wilhelm, et al.. (2017). The subcutaneous implantable cardioverter defibrillator in daily clinical practice. Swiss Medical Weekly. 147(4142). w14518–w14518. 1 indexed citations
15.
Haegeli, Laurent, Thomas Wölber, Nazmi Krasniqi, et al.. (2016). Akuter Ablationserfolg supraventrikulärer Tachykardien - Erfahrungen eines tertiären Zentrums. Cardiovascular Medicine. 19(9). 231–236.
16.
Steffel, Jan, Robert P. Giugliano, Eugene Braunwald, et al.. (2015). Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 Trial. Circulation. 132(suppl_3). 4 indexed citations
17.
Saguner, Ardan M., Andrea Kraus, Samuel H. Baldinger, et al.. (2015). Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia. BMC Cardiovascular Disorders. 15(1). 4–4. 27 indexed citations
18.
Starck, Christoph, Jan Steffel, Tomáš Holubec, & Volkmar Falk. (2015). Current aspects of atrial fibrillation surgery. Cardiovascular Medicine. 18(6). 181–185. 2 indexed citations
19.
Hürlimann, David, Christoph Starck, G Hindricks, et al.. (2013). Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. European Heart Journal. 35(16). 1051–1060. 42 indexed citations
20.
Camici, Giovanni G., Jan Steffel, Alexander Akhmedov, et al.. (2006). Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation. Circulation. 114(14). 1512–1521. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Tanguay Breakdown of academic impact, for papers by Jonathan D. Marmur Breakdown of academic impact, for papers by Juan F. Viles-González Breakdown of academic impact, for papers by Nauder Faraday Breakdown of academic impact, for papers by Seiji Hokimoto Breakdown of academic impact, for papers by Axel Schlitt Breakdown of academic impact, for papers by T. Brett Reece Breakdown of academic impact, for papers by Michael T. Watkins Breakdown of academic impact, for papers by Nicolas Amabile Breakdown of academic impact, for papers by Stephan H. Schirmer
Rankless by CCL
2026